Improved Detection of Minimal Residual Disease in AML: Validation of IDH1/2 ddPCR Assays in the Perspective of Treatment with Target Inhibitors. [PDF]
Nikitsenka K +9 more
europepmc +1 more source
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients [PDF]
Stefania Crucitta +11 more
openalex +1 more source
Rare IDH hotspot mutations in dysembryoplastic neuroepithelial tumors expand the spectrum of IDH-altered CNS tumors. [PDF]
Raby M +16 more
europepmc +1 more source
Single-cell multi-omics identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma. [PDF]
Veo B +11 more
europepmc +1 more source
Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy forIDH1mutant glioma [PDF]
Hiroaki Nagashima +14 more
openalex +1 more source
Next-Generation Sequencing Reveals a Diagnostic and Prognostic Role of the <i>TP53</i> R273C Mutation in Lower-Grade, <i>IDH</i>-Mutant Astrocytomas. [PDF]
Navarro L +5 more
europepmc +1 more source

